Treatment of children from 6 to 11 years old affected by moderate-severe atopic dermatitis with dupilumab: a first perspective from a single-center real-life experience in Italy.
C ColonnaMartina ZussinoNicola Adriano MonzaniAlessandra PonzianiR CavalliPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2022)